*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : CO4825000
CHEMICAL NAME : 1-Azulenesulfonic acid, 3-ethyl-7-(1-methylethyl)-,
sodium salt
CAS REGISTRY NUMBER : 97683-31-3
OTHER CAS REGISTRY NOS. : 130442-59-0
LAST UPDATED : 199509
DATA ITEMS CITED : 14
MOLECULAR FORMULA : C15-H17-O3-S.Na
MOLECULAR WEIGHT : 300.37
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Azuletil sodium
* 3-Ethyl-7-(1-methylethyl)-1-azulenesulfonic acid sodium salt
* KT 1-32
* Sodium 3-ethyl-7-isopropyl-1-azulenesulfonate
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1096 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 224 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 364 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 730 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 373 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 364 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4359,1990
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Gastrointestinal - nausea or vomiting
Liver - hepatitis (hepatocellular necrosis), zonal
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4367,1990
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 28 gm/kg/28D-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4403,1990
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 45 gm/kg/13W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Related to Chronic Data - death
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4379,1990
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 110 gm/kg/1Y-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in both tubules and glomeruli
Kidney, Ureter, Bladder - urine volume increased
Kidney, Ureter, Bladder - changes in bladder weight
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4449,1990
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 45500 mg/kg/13W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in both tubules and glomeruli
Kidney, Ureter, Bladder - changes in bladder weight
Endocrine - changes in adrenal weight
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4419,1990
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 73 gm/kg/1Y-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased
Blood - other changes
Biochemical - Metabolism (Intermediary) - lipids including transport
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,4483,1990
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 7200 mg/kg
SEX/DURATION : female 6-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 19,1335,1991
** MUTATION DATA **
TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 440 mg/L
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 18,2597,1990
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
8-Azoniabicyclo(3.2.1)octane,8,8'-(1,5-pentanediyl)bis(3-(3-hydroxy-1-oxo-2-phenylpropoxy)- 8-methyl-, diiodide
| 941-14-0 |
3-Azoniabicyclo(3.2.1)octane,1,3,8,8-tetramethyl-3-(3-(trimethylammonio)propyl)-,bis(methyl sulfate)
| 14149-43-0 |
3-Azoniabicyclo(3.2.1)octane,1,3,8,8-tetramethyl-3-(3-(trimethylammonio)propyl)-,dichloride
| 14149-43-0 |
3-Azoniabicyclo(3.2.1)octane,1,3,8,8-tetramethyl-3-(3-(trimethylammonio)propyl)-,diiodide
| 58594-48-2 |
1-Azoniabicyclo(3.2.1)octan-6-ol, 1-methyl-, bromide,diphenylacetate
| 69766-47-8 |
Azirino(2',3'3,4)pyrrolo(1,2-a)indole-4,7-dione,1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methyl-8-methylene-,(1aS-(1a-alpha,8a-alpha,8b-alpha))-
| 74422-30-3 |
17a-Azonia-D-honoandrostane,17a,17a-dimethyl-3-(1-methylpyrrolidinio)-, dibromide
| 70433-02-2 |
1-Azoniaspiro(4.5)decane,1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide
| 70433-02-2 |
1-Azoniaspiro(4.5)decane,1-(3-(dimethylcarbamoyl)-3,3-diphenylpropyl)-1-methyl-, bromide
| 70433-02-2 |
2-Azoniaspiro(4.5)decane, 2-dodecyl-2-methyl-, iodide
| 798-02-7 |
8-Azoniaspiro(4.5)decane,8-(3-(p-fluorobenzoyl)propyl)-8-methyl-, iodide
| 1096-06-6 |
5-Azoniaspiro(4.5)decane,2-hydroxy-2-methyl-1-methylene-, iodide
| 41598-48-5 |
2-Azoniaspiro(4.4)nonane, 2-allyl-2-methyl-, iodide
| 41598-48-5 |
5-Azoniaspiro(4.4)nonane,2-((cyclohexylhydroxyphenylacetyl)oxy)-, bromide
| 76302-53-9 |
5-Azoniaspiro(4.4)nonane,2-((cyclopentylhydroxyphenylacetyl)oxy)-, bromide
| 76302-54-0 |
5-Azoniaspiro(4.4)nonane,2-((hydroxydiphenylacetyl)oxy)-, bromide
| 76302-54-0 |
Azirino(2',3'3,4)pyrrolo(1,2-a)indole-4,7-dione,1,1a,2,8,8a,8b-hexahydro-6-dimethylamino-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate
| 4049-15-4 |
6-Azoniaspiro(5,5)undecane bromide
| 6286-82-4 |
3-Azoniaspiro(5.5)undecane, 3,3,9-trimethyl-, iodide
| 775-73-5 |
1H-Azonine-1-ethanol, octahydro-, benzilate,hydrochloride
| 99901-10-7 |
1H-Azonine-1-ethanol, octahydro-beta-methyl-,benzilate, hydrochloride
| 99901-11-8 |
1H-Azonine, octahydro-1-nitroso-
| 20917-50-4 |
2-Azoninethione, octahydro-, (Z)-
| 20917-50-4 |
Azoninium,octahydro-1-(5-octahydroazonino-2,4-pentadienylidene)-, chloride
| 23996-86-3 |
2H-Azonin-2-one, octahydro-
| 935-30-8 |
2-Azoninone, octahydro-, (Z)-
| 935-30-8 |
m,o'-Azotoluene, 4-nitro-
| 17277-81-5 |
Azirino(2',3'3,4)pyrrolo(1,2-a)indole-4,7-dione,1,1a,2,8,8a,8b-hexahydro-6-(((dimethylamino)methylene)amino)-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester)
| 88949-01-3 |
Azotrex
| 8054-08-8 |
Azoxybenzene
| 495-48-7 |
Azoxybenzene, 3,3'-bis(dichloroarsino)-
| 495-48-7 |
Azoxybenzene, 4,4'-dichloro-
| 614-26-6 |
Azoxybenzene, 5,5'-dichloro-2,2'-dimethyl-
| 66941-45-5 |
Azoxybenzene, 3,3',4,4'-tetrachloro-
| 21232-47-3 |
Azulene
| 275-51-4 |
1-Azulenecarboxaldehyde,4-methyl-7-(1-methylethenyl)-
| 85-33-6 |
1-Azulenecarboxamide,3-acetamido-N-(2-(diethylamino)ethyl)-, hydrochloride
| 54805-31-1 |
1-Azulenecarboxamide, N-(2-(diethylamino)ethyl)-,hydrochloride
| 54805-26-4 |
Azirino(2',3'3,4)pyrrolo(1,2-a)indole-4,7-dione,1,1a,2,8,8a,8b-hexahydro-1,5-dimethyl-6-dimethylamino-8a-hydroxy-8-(hydroxymethyl)-,8-carbamate
| 30823-13-3 |
1-Azulenecarboxamide,N-(2-(diethylamino)ethyl)-3-nitro-, hydrochloride
| 54805-30-0 |
Azulenecarboxamide, 1-(N-methylpiperazinyl)-,hydrochloride
| 54805-27-5 |
Azulenecarboxamide, 1-(N-methylpiperazinyl)-3-nitro-,hydrochloride
| 54805-28-6 |
Azulenecarboxylic acid
| 64059-36-5 |
5,6-Azulenedicarboxaldehyde,1,2,3,3a,8,8a-hexahydro-3a-hydroxy-2,2,8-trimethyl-,(3aS-(3a- alpha,8-alpha,8a-alpha))-
| 96910-73-5 |
Azulene, 1,4-dimethyl-7-ethyl-
| 529-05-5 |
Azulene, 1,4-dimethyl-7-isopropyl-
| 489-84-9 |
1-Azulenemethanol, 4-methyl-7-(1-methylethenyl)-
| 113393-59-2 |
Azulene,1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethylidene)-, monoepoxide
| 68071-23-8 |
1-Azulenesulfonic acid, 3-ethyl-7-(1-methylethyl)-,sodium salt
| 97683-31-3 |
Azirino(2',3'3,4)pyrrolo(1,2-a)indole-4,7-dione,1,1a,2,8,8a,8b-hexahydro-1,5-dimethyl-6-(ethylamino)-8a-alpha-hydroxy-8-(hydroxymethyl)-,8-carbamate
| 21448-81-7 |
|
|